Bill > S1420

This bill makes several changes to Florida's medical practice laws, primarily concerning the prescribing of controlled substances and the supervision of physician assistants (PAs). It exempts certain physicians who prescribe controlled substances for pain management in patients with sickle cell disease from specific standards of practice, recognizing the unique needs of these patients. Additionally, the bill removes the previous limit on the number of PAs a physician can supervise, allowing for greater flexibility in healthcare team staffing. It also clarifies and modifies the list of drugs that PAs are prohibited from prescribing, specifying that controlled substances listed under schedules I and II of chapter 893 are included on this formulary. The bill also updates requirements for PA licensure and renewal, including continuing education and application documentation, and makes technical amendments to existing statutes.